|
US6004925A
(en)
*
|
1997-09-29 |
1999-12-21 |
J. L. Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6518412B1
(en)
*
|
1997-09-29 |
2003-02-11 |
Jean-Louis Dasseux |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6253569B1
(en)
*
|
1999-05-07 |
2001-07-03 |
James J. Hall |
Portable storage unit for game animals
|
|
US7199102B2
(en)
|
2000-08-24 |
2007-04-03 |
The Regents Of The University Of California |
Orally administered peptides synergize statin activity
|
|
US7166578B2
(en)
|
2000-08-24 |
2007-01-23 |
The Regents Of The University Of California |
Orally administered peptides synergize statin activity
|
|
US7144862B2
(en)
|
2000-08-24 |
2006-12-05 |
The Regents Of The University Of California |
Orally administered peptides to ameliorate atherosclerosis
|
|
US7723303B2
(en)
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
US7148197B2
(en)
*
|
2000-08-24 |
2006-12-12 |
The Regents Of The University Of California |
Orally administered small peptides synergize statin activity
|
|
US6664230B1
(en)
|
2000-08-24 |
2003-12-16 |
The Regents Of The University Of California |
Orally administered peptides to ameliorate atherosclerosis
|
|
US8124625B2
(en)
|
2001-09-14 |
2012-02-28 |
Shionogi & Co., Ltd. |
Method of enhancing the expression of apolipoprotein AI using olefin derivatives
|
|
US7429593B2
(en)
|
2001-09-14 |
2008-09-30 |
Shionogi & Co., Ltd. |
Utilities of amide compounds
|
|
US20040235877A1
(en)
|
2001-09-14 |
2004-11-25 |
Natsuki Ishizuka |
Novel use of tricyclic compound
|
|
US6930085B2
(en)
*
|
2002-04-05 |
2005-08-16 |
The Regents Of The University Of California |
G-type peptides to ameliorate atherosclerosis
|
|
NZ555826A
(en)
|
2004-12-06 |
2009-11-27 |
Univ California |
Methods for improving the structure and function of arterioles
|
|
WO2009032702A2
(en)
|
2007-08-28 |
2009-03-12 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
US9422363B2
(en)
|
2007-08-28 |
2016-08-23 |
Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
|
EA018620B1
(ru)
*
|
2008-10-30 |
2013-09-30 |
Сёркомед Ллк |
ПРОИЗВОДНЫЕ ТИЕНОТРИАЗОЛОДИАЗЕПИНА, АКТИВНЫЕ В ОТНОШЕНИИ Apo A1
|
|
CA2799420C
(en)
|
2010-05-14 |
2018-10-02 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
|
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
|
CA2799373A1
(en)
*
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
CA2799403C
(en)
|
2010-05-14 |
2020-01-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating leukemia
|
|
JP2016531113A
(ja)
|
2013-07-25 |
2016-10-06 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
転写因子の阻害剤およびその使用
|
|
MX379463B
(es)
|
2013-11-08 |
2025-03-10 |
Dana Farber Cancer Inst Inc |
Terapia de combinación para el cáncer usando inhibidores de la proteína bromodominio y extra-terminal.
|
|
MX2016009974A
(es)
|
2014-01-31 |
2016-10-31 |
Dana Farber Cancer Inst Inc |
Derivados de diaminopirimidina bencensulfona y sus usos.
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
RU2722179C2
(ru)
|
2014-02-28 |
2020-05-28 |
Тэнша Терапеутикс, Инк. |
Лечение состояний, ассоциированных с гиперинсулинемией
|
|
USRE50320E1
(en)
|
2014-07-31 |
2025-03-04 |
Uab Research Foundation |
APOE mimetic peptides and higher potency to clear plasma cholesterol
|
|
KR20170032474A
(ko)
|
2014-08-08 |
2017-03-22 |
다나-파버 캔서 인스티튜트 인크. |
디히드로프테리디논 유도체 및 그의 용도
|
|
EP3177626A4
(en)
|
2014-08-08 |
2017-12-27 |
Dana Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
BR112017008714A2
(pt)
|
2014-10-27 |
2017-12-19 |
Tensha Therapeutics Inc |
inibidores de bromodomínio
|
|
US10702527B2
(en)
|
2015-06-12 |
2020-07-07 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
KR20180049058A
(ko)
|
2015-09-11 |
2018-05-10 |
다나-파버 캔서 인스티튜트 인크. |
시아노 티에노트리아졸로디아제핀 및 그의 용도
|
|
CA2996977A1
(en)
|
2015-09-11 |
2017-03-16 |
Dana-Farber Cancer Institute, Inc. |
Acetamide thienotriazolodiazepines and uses thereof
|
|
SG10201913450PA
(en)
|
2015-11-25 |
2020-03-30 |
Dana Farber Cancer Inst Inc |
Bivalent bromodomain inhibitors and uses thereof
|
|
EA202092635A1
(ru)
|
2018-06-13 |
2021-03-23 |
Дибли Аг |
Получение конденсированных производных триазепина и их применение в качестве ингибиторов bet
|